The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The U.S. Food and Drug Administration issued its most stringent warning Friday for a higher-dose version of the Pfizer drug Xeljanz, five months after a clinical trial showed it was linked to ...